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ABSTRACT 
The present study aimed to synthesize and characterize dehydrozingerone as well as to 
investigate its anticonvulsant activity in experimental animals.  A simple method was used to 
synthesize dehydrozingerone using vanillin and acetone. The synthesized drug dehydrozingerone 
was characterized using thin layer chromatography (TLC), high performance liquid 
chromatography (HPLC), infrared spectroscopy (IR) and physicochemical tests.The synthesized 
product was  tested for its potential anticonvulsant activity using maximum electroshock (MES) 
induced seizure models in rats. The synthesized dehydrozingerone showed TLC profile, FT IR 
spectra and HPLC chromatogram similar to the authentic sample. The physicochemical 
characters (colour, taste, flavour, solubility and melting point) were also similar to what was 
found in the literature. All these results indicated that the produced product was 
dehydrozingerone. A dose dependent anticonvulsant activity was produced by dehydrozingerone. 
Eighty percent anti-MES activity was presented by 100 mg/kg.  The findings indicated that 
dehydrozingerone represents a bioactive molecule possessing anticonvulsant activity. In 
addition, it is an easily synthesized compound from cheap starting materials. In conclusion 
dehydrozingerone may find its place as antiepileptic agent if further clinical studies will be 
conducted. 
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INTRODUCTION 
Dehydrozingerone is a pungent constituent present in the rhizomes of ginger (Zingiber officinale) 
and belongs structurally to the vanillyl ketone class (Yogosawa et al., 2012). Dehydrozingerone 
  
 
 
Gezira Journal of Engineering and Applied Sciences vol ( 21 ) num-1-20 71  
 
Gezira Journal of Engineering and Applied Sciences vol ( 21 ) num-1-20 71  
 
is reported to possess many biological activities such as: antioxidant (Kuo et al., 2005), 
antitumor (Motohashi et al., 1998), inhibitory effect on vascular smooth muscle cell 
function(Yizhen et al., 2008) and antifungal(Kubra et al., 2012) activities. The present study 
aimed to synthesize and characterize dehydrozingerone as well as to investigate its 
anticonvulsant activity in experimental animals. 
 
 
Dehydrozingerone 
Product category               : Aromatic ketone 
Molecular formula            : 3O12H11C 
Molecular weight              : 192.2 
Melting point                    : 125-130 °C 
Boiling point                     : 348.2 °C 
Synonyms                         : Dehydrogingerone 
Dehydro[0]-paradol 
Feruloylmethane 
3-Methoxy-4-hydroxybenzalacetone 
4-(4-hydroxy-3-methoxyphenyl)-3-buten-2-one 
4-hydroxy-3-methoxystyrylmethylketone 
 
 
 
 
MATERIALS AND METHODS 
MATERIALS 
Chemicals:  
Pentylentetrazole, dehydrozingerone and vanillin were purchased from Sigma-Aldrich, UK, 
were obtained from Loba  20sodium hydroxide and tweenacetone, hydrochloric acid, ethanol, 
Chemie, India. 
METHODS 
 
Preparation of working solutions of chemicals: 
 
Freshly prepared solutions of pentylentetrazole dissolved in normal saline and dehydrozingerone 
were used.20 dissolved in 5% tween 
 
Experimental animals:  
 
Albino rats of both sexes weighing 150 – 200 g were used. The animals were kept and 
maintained under appropriate laboratory conditions, allowed free access to water and fasted for 
an over night before the experiment. 
Synthesis of dehydrozingerone: 
OCH3
H
O
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+
O
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Vanillin (4g) was placed in a beaker. Acetone (20 ml) and 10% sodium hydroxide solution (20 
ml) were added to vanillin. The mixture was stirred, stoppered and allowed to stand for 48 hours. 
After standing, the dark colored mixture is acidified with 10% hydrochloric acid (60 ml), placed 
in an ice bath and stirred. Upon acidification and stirring a yellowish-brown solid was formed. 
The solid material was filtered and washed several times with cold water. The crude product was 
recrystallized from 50% aqueous ethanol (Allen et al., 2006). 
Identification of dehydrozingerone: 
Melting point determination: 
 
The melting point of the synthetic dehydrozingerone was determined in sealed capillary tubes on 
an electrothermal melting point apparatus (Veego Scientific MP-D. India). Results were the 
mean of triplicate readings. 
Thin layer chromatography (TLC) for synthetic dehydrozingerone: 
The synthesized dehydrozingerone and the standard reference were chromatographed on TLC 
sheet, silica gel 60 of thickness 0.2mm (Riedel-de Haen AG. Seelze Germany) using toluene and 
values were  fpoure was used as locating agent. Rethyl acetate (93: 7) as solvent system. Iodine va
calculated.  
 
Infrared spectroscopy (FT IR) for synthetic dehydrozingerone: 
 
IR spectra of both synthesized and reference dehydrozingerone were recorded on FTIR 
spectrophotometer-8400 S (Shimadzu-Japan), using KBr disk of IR spectroscopic grade 
(Shimadzu Laboratory reagents, Japan). 
High performance liquid chromatography (HPLC) for synthetic dehydrozingerone: 
 
The synthesized dehydrozingerone and the standard reference were analyzed by high 
performance liquid chromatography (Waters, USA) equipped with Shim-pack VP-ODS column 
C18 (250* 4.6 mm). Isocratic elution was performed using a mixture of HPLC grade methanol 
C. Photodiode Array Detector was ๐and water (65:35 v/v), flow rate 1.0ml/min, temperature 28
set at 280nm. Sample injection volume was 20 μl. 
Maximal electroshock-induced seizure test: 
 
Maximal electroshock (MES) seizure model was used to evaluate the anticonvulsant activity of 
dehydrozingerone. Seizures were induced in rats by delivering electroshock of 50 mA for 0.5 
second by means of an electro- convulsiometer (Ugobasile ECT unit 57800) through a pair of ear 
clip electrodes (Kumar et al., 2008). Six groups of rats of both sexes were used. Three groups of 
rats (n=5) received dehydrozingerone (10, 50 and 100 mg/kg) intraperitoneally (i.p) (Manigauha 
et al., 2009). Thirty minutes later rats were tested for MES induced seizure response. Two 
groups of rats (n=3) received sodium valporoate (300 and 400 mg/kg) injected i.p. and tested 
after 15 minutes for MES induced seizure response. All the experimental groups were compared 
). 20to a control group administered the vehicle (tween 
 
 
 
 
 
  
 
 
Gezira Journal of Engineering and Applied Sciences vol ( 21 ) num-1-20 71  
 
Gezira Journal of Engineering and Applied Sciences vol ( 21 ) num-1-20 71  
 
 
 
 
 
 
 
 
RESULTS AND DISCUSSION 
 
Synthesis and identification of dehydrozingerone (DZ): 
 
) synthesis, in which 3O12H11Literature reports showed an easy method for dehydrozingerone (C
two starting materials, vanillin and acetone were, used (Allen et al., 2006). .  
 
 
 
 
Fig. 1: Synthesis of dehydrozingerone. 
 
The reactions produced fragrant, brilliant yellow powder of good yield (1.99 g; 50%). The 
powder is soluble in alcohol and insoluble in water. Melting point was determined as being 126-
127 °C. Results obtained agree with what has been reported by Allen et al., (2006). The 
conducted DZ synthetic method produced a considerable yield of the product in lower number of 
steps. TLC profiles (Fig. 2), HPLC chromatograms (Fig. 3) and FT IR spectra (Fig. 4) of the 
synthesized dehydrozingerone (SDZ) are almost matching with those obtained from 
value (0.2) was observed using  fdehydrozingerone (DZ) standard sample. For TLC, identical R
iodine vapour as locating agent whereas HPLC analysis revealed similar retention time (1.32 
minute).   
FT IR spectra represents bands at 3303 (broad band), 3001, 2948, 2848, 2362, 1676, 1637, 1581, 
1517, 1452, 1425, 1367, 1298, 1263, 1224, 1166, 1122, 1024, 979, 937, 875, 821, 804, 756, 671, 
 .
1-
576, 543, and 464 cm 
1581 -ble in the region (3303The characteristic and diagnostic bands of dehydrozingerone are visi
., 2008; Dudley and Fleming, 1980) et al., 2009; Hatzade et al). All the literature (Hatzade 1–cm
-H bond. Two characteristic aryl C-to the stretching of O1 –agrees in assigning a band at 3303 cm
H stretching appeared -. Aliphatic C1-and 2362 cm1 -at 3001 cmH stretching bands also appeared 
. Carbonyl conjugated double bond stretching was represented by a band at 1-at 2948 and 2848 cm
. In addition the 1-and 1581cm 1-. Aromatic C=C stretching appeared at 1637cm1-1676 cm
overcrowded lower IR fingerprint region of dehydrozingerone, where many absorption bands 
for  1–occur was found to be identical to the reference sample, presenting band at 1224 cm
OCH3
H
O
HO
+
O
1)
2)H2O,HCl
O
OCH3
HO
+H2O
NaOH
Acetone Vanillin 
                     Dehydrozingerone (SDZ) 
[4-(4’-hydroxy-3’-methoxyphenyl)-3-butene-2-one] 
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 C-O-H bending and aryl alkyl ether of characteristic two peaks; asymmetric   C-phenolic O
 .1-and a symmetric stretch at 1024cm 1-stretch at 1263 cm 
The analytical data obtained and physicochemical characters (colour, taste, flavour, solubility 
and melting point), TLC profile, FT IR spectrum and HPLC chromatogram for the SDZ coincide 
with those of the reference sample as well as they match with data shown in the literature 
confirming that the synthesized compound was indeed dehydrozingerone . 
 
 
               
   Fig.2: TLC chromatogram of (a): synthesized dehydrozingerone 
                            (b): reference dehydrozingerone. 
 
 
 
 
 
a b 
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A) 
 
B) 
 
 
Fig. 3: HPLC chromatogram of (A) Reference dehydrozingerone (B) Synthetic 
dehydrozingerone. 
 A) 
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B) 
 
Fig.4: FTIR spectra of (A) Reference dehydrozingerone (B) synthetic  
           dehydrozingerone. 
 
Anticonvulsant activity of the synthesized dehydrozingerone: 
As shown in Table 1 dehydrozingerone produced a dose dependent anticonvulsant activity in the 
maximum electroshocks seizure model used. High doses were required to prevent seizure 
induced by MES. Eighty percent anti-MES activity was presented by 100mg/kg. There was no 
previous reported data about the anticonvulsant activity of dehydrozingerone. Dehydrozingerone 
presents a reactive molecule containing vanillyl aromatic moiety, conjugated double bond 
system, reactive carbonyl group and capability of hydrogen bonding, all that may contribute to 
its anticonvulsant activity.  
 
Table 1: Anti-maximum electroshocks (MES) activity of the synthetic    
dehydrozingerone . 
15003000
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Treatment Vehicle 
Sodium valporoate 
(standard) 
Dehydrozingerone 
Dose mg/kg 10ml/kg 300 400 10 50 100 
Seizure protection (%) 0.00 66.6 100 20 40 80 
 
CONCLUSIONS 
 
The findings indicated that dehydrozingerone represents a bioactive molecule possessing 
anticonvulsant activity. In addition, it is an easily synthesized compound from cheap starting 
materials. In conclusion dehydrozingerone may find its place as antiepileptic agent if further 
clinical studies are conducted. 
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  النشاط المضاد للتشنجات لمركب ديهايدروزينجرون استقصاءتمييز و تصنيع و 
 
 ايناس محمد عوض1*,الهادي محمد محمد احمد2  ,
 طارق محمد هاشم الهدية 3 , نزار سراج 2 و محمد عبدالرحمن4
 
  جامعة الجزيرة. -كلية الصيدلة -. قسم الكيمياء الصيدلانية  1
 2 . جامعة الجزيرة. -كلية الصيدلة -قسم العقاقير الطبية 
  جامعة الأحفاد للبنات. -مدرسة الصيدلة -. وحدة علم الأدوية والعلاجيات 3
  جامعة الجزيرة. -كلية الصيدلة -قسم الصيدلانيات .4
 
 الملخص
هدفت هذه  الدراسة لتصنيع وتمييز واستقصاء النشاط المضاد للتشنجات علي حيوانات التجارب لمركب  
ديهايدروزنجرون. تم استخدام طريقة بسيطة لتصنيع مركب ديهايدروزنجرون باستخدام فانيلين واسيتون. تم تمييز 
كروماتوغرافيا السوائل عالية الكفاءة, الاشعة تحت الحمراء  ,قة الرقيقةالمركب المصنع باستخدام كروماتوغرافيا الطب
ي المحدثة و تم اختبار النشاط المضاد للتشنجات باستخدام الصدمة الكهربية القص والاختبارات الفيزيائية الكيميائية .
 أللنوبات في الجرذان. 
 
يا طبقة الرقيقة, كروماتوغرافمع كروماتوغرافيا ال ظهر مركب ديهايدروزنجرون المصنع تطابقا
كانت الخصائص الفيزيائية الكيميائية (اللون,  السوائل عالية الكفاءة, الاشعة تحت الحمراء للمركب المرجع. كذلك
مركب لا ن هذا أالطعم, النكهة, الذوبانية ودرجة الانصهار) مشابهة لما ورد في الادبيات السابقة. دلت كل  النتائج علي 
 أديهايدروزنجرون. المصنع هو 
 
  حدث المركب المصنع نشاطا
 
  مضادا
 
 %80علي الجرعة حيث نتجت  للتشنجات معتمدا
ملجم/كجم. أكدت النتائج أن مركب ديهايدروزنجرون يمثل جزيئة حيوية نشطة  881حماية من النوبات عند الجرعة 
 
 
  تمتلك نشاطا
 
 إلك فذللتشنجات. ك مضادا
 
  مواد أولية رخيصة. ه مركب سهل التصنيع باستخدامن
 
 خلصت الدراسة إلى أن
 مركب ديهايدروزنجرون يمكن أن يمثل مادة مضادة للتشنجات إذا تم إجراء مزيد من الدراسات السريرية.
 
 
